Cynthia Pussinen
Chief Executive Officer bei SERNOVA CORP.
Vermögen: - $ am 31.03.2024
Profil
Cynthia Pussinen is currently the Chief Executive Officer & Director at Sernova Corp.
Prior to her current position, she served as the Chief Technical Officer at Spark Therapeutics, Inc. from 2021 to 2022.
She also held the position of Executive Vice President-Technical Development at Actinium Pharmaceuticals, Inc. Ms. Pussinen holds a graduate degree from Rensselaer Polytechnic Institute and an undergraduate degree from the University of Connecticut.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SERNOVA CORP.
-.--% | 05.09.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Cynthia Pussinen
| Unternehmen | Position | Beginn |
|---|---|---|
| SERNOVA CORP. | Chief Executive Officer | 05.09.2023 |
Ehemalige bekannte Positionen von Cynthia Pussinen
| Unternehmen | Position | Ende |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.12.2022 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Cynthia Pussinen
| Rensselaer Polytechnic Institute | Graduate Degree |
| University of Connecticut | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SERNOVA CORP. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
